Back to drug

The Drug-Induced Respiratory Disease Website

May reverse with drug discontinuation. Generally similar to primary PHTn clinically, hemodynamically and on pathology. PMID 23997051. A few cases are thromboembolic in nature (PMID 24881082). Reviews at PMID 29508628, 30545968

Publications

Kolaitis NA, Saggar R, De Marco T

Methamphetamine-associated pulmonary arterial hypertension.

Current opinion in pulmonary medicine 2022 Sep 01;28;352-360 — 2022 Sep 01 — 352-360

Ramirez RL, Perez VJ, Zamanian RT

Methamphetamine and the risk of pulmonary arterial hypertension.

Current opinion in pulmonary medicine 2018 09;24;416-424 — 2018 09 — 416-424

de Jesus Perez V, Kudelko K, Snook S, Zamanian RT

Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.

International journal of clinical practice. Supplement 2011 Jan;;8-10 — 2011 Jan — 8-10

Thompson CA

Pulmonary arterial hypertension seen in methamphetamine abusers.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008 Jun 15;65;1109-10 — 2008 Jun 15 — 1109-10

Chin KM, Channick RN, Rubin LJ

Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Chest 2006 Dec;130;1657-63 — 2006 Dec — 1657-63

Albertson TE, Derlet RW, Van Hoozen BE

Methamphetamine and the expanding complications of amphetamines.

The Western journal of medicine 1999 Apr;170;214-9 — 1999 Apr — 214-9

Schaiberger PH, Kennedy TC, Miller FC, Gal J, Petty TL

Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine.

Chest 1993 Aug;104;614-6 — 1993 Aug — 614-6